Market Closed -
Canadian Securities Exchange
13:34:38 2024-02-06 EST
|
5-day change
|
1st Jan Change
|
0.015
CAD
|
+50.00%
|
|
-.--%
|
+50.00%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1.631
|
3.443
|
1.45
|
0.5437
|
Enterprise Value (EV)
1 |
0.6092
|
3.062
|
1.533
|
0.7563
|
P/E ratio
|
-1.38
x
|
-4.83
x
|
-2.49
x
|
-2.73
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
-1,816,988
x
|
-7,301,554
x
|
-6,153,219
x
|
-16,897,583
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
1.69
x
|
8.34
x
|
-18.9
x
|
-1.98
x
|
Nbr of stocks (in thousands)
|
36,247
|
36,247
|
36,247
|
36,247
|
Reference price
2 |
0.0450
|
0.0950
|
0.0400
|
0.0150
|
Announcement Date
|
3/9/20
|
3/15/21
|
5/2/22
|
4/6/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.7838
|
-0.6748
|
-0.5303
|
-0.4943
|
-0.162
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.9216
|
-0.7672
|
-0.5528
|
-0.5245
|
-0.1983
|
Net income
1 |
-0.9216
|
-0.7672
|
-0.5528
|
-0.5245
|
-0.1983
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.0580
|
-0.0326
|
-0.0197
|
-0.0161
|
-0.005492
|
Free Cash Flow
|
-
|
-0.3353
|
-0.4194
|
-0.2491
|
-0.0448
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/29/19
|
3/9/20
|
3/15/21
|
5/2/22
|
4/6/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
0.08
|
0.21
|
Net Cash position
1 |
0.48
|
1.02
|
0.38
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.34
|
-0.42
|
-0.25
|
-0.04
|
ROE (net income / shareholders' equity)
|
-
|
-110%
|
-80.2%
|
-312%
|
113%
|
ROA (Net income/ Total Assets)
|
-
|
-52.4%
|
-44.3%
|
-111%
|
-110%
|
Assets
1 |
-
|
1.463
|
1.248
|
0.4735
|
0.1806
|
Book Value Per Share
2 |
0.0100
|
0.0300
|
0.0100
|
-0
|
-0.0100
|
Cash Flow per Share
2 |
0.0200
|
0.0300
|
0.0100
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/29/19
|
3/9/20
|
3/15/21
|
5/2/22
|
4/6/23
|
|
1st Jan change
|
Capi.
|
---|
| +50.00% | 400K | | +45.15% | 6.38B | | -14.00% | 4.59B | | +9.54% | 3.39B | | -8.99% | 3.2B | | -2.41% | 2.52B | | +50.03% | 2B | | -6.97% | 1.7B | | -0.31% | 1.65B | | -10.61% | 1.58B |
Alternative Medicine
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly** -40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff** BENEFIT NOW**0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
|